SEASTAR MEDICAL HOLDING CORP (ICU) Stock Earnings Estimates
NASDAQ:ICU • US81256L3024
2.56 USD
-0.15 (-5.54%)
Last: Mar 3, 2026, 04:30 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 135K | 1.544M 1,043.70% | 2.393M 54.99% | 3.337M 39.45% | |||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -11.61M -160.90% | -14.21M -22.39% | -17.842M -25.56% | -12.514M 29.86% | -15.312M -22.35% | -15.122M 1.24% | |
| Operating Margin | N/A | N/A | -13,216.30% | -810.52% | -639.85% | -453.17% | |
| EPS YoY % growth | N/A | N/A | -7.78 97.32% | -6.44 17.17% | -3.38 47.57% | -2.57 24.07% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.07 -18.96% | -1.07 75.67% | -1.11 38.28% | -1.11 14.54% | -0.11 89.62% |
| Revenue Q2Q % growth | 376.225K 461.53% | 378.75K 29.27% | 477.73K 41.34% | 354.51K 93.72% | 544.39K 44.70% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -3.597M 24.54% | -4.159M -8.82% | -4.42M -151.69% | -4.997M -39.63% | -5.331M -48.20% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -1.30 -18.18% | -1.52 | 0.22 | 14.19% |
| Q2 2025 Q2Q % growth | -1.80 -74.76% | -4.34 | 2.54 | 58.55% |
| Q1 2025 Q2Q % growth | -4.40 7.37% | -5.25 | 0.85 | 16.22% |
| Q4 2024 Q2Q % growth | -0.90 83.64% | -0.90 | 0.00 | -0.12% |
| Q3 2024 Q2Q % growth | -1.10 87.78% | -1.14 | 0.04 | 3.62% |
| Q2 2024 Q2Q % growth | -1.03 85.29% | -1.42 | 0.39 | 27.67% |
| Q1 2024 Q2Q % growth | -4.75 | -3.79 | -0.96 | -25.41% |
| Q4 2023 Q2Q % growth | -5.50 | -3.28 | -2.22 | -67.56% |
| Q3 2023 Q2Q % growth | -9.00 | -6.31 | -2.69 | -42.57% |
| Q2 2023 Q2Q % growth | -7.00 | -6.31 | -0.69 | -10.89% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 183K 169.12% | 252.5K | -69.5K | -27.52% |
| Q2 2025 Q2Q % growth | 338K | 202K | 136K | 67.33% |
| Q1 2025 Q2Q % growth | 293K | 151.5K | 141.5K | 93.40% |
| Q4 2024 Q2Q % growth | 67K | 151.5K | -84.5K | -55.78% |
| Q3 2024 Q2Q % growth | 68K | 75.75K | -7.75K | -10.23% |
| Q2 2024 Q2Q % growth | 10.1K | -10.1K | -100.00% | |
| Q1 2024 Q2Q % growth | 151.5K | -151.5K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -2.42% | -715.38% | -4.16% | -786.11% |
| Revenue | 0% | 52.04% | 0% | 24.32% |